Olimel N9

Valine, the active ingredient in Olimel N9, is a amino acid presented as an unknown strength/unknown form for intravenous use. It is combined with other amino acids and is intended for clinical settings where amino acid supplementation may be required. GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Olimel N9 contains a blend of essential and non‑essential amino acids used in clinical nutrition and metabolic support.

- Metabolic support: Helps maintain nitrogen balance in patients requiring parenteral nutrition. - Post‑operative recovery: Supports protein synthesis during recovery after major surgery. - Critical care: Provides essential amino acids for patients in intensive care units. - Trauma care: Assists in tissue repair and healing in trauma patients. - Liver disease management: Contributes to nutritional management of liver dysfunction.

Side effects associated with intravenous amino‑acid solutions are generally related to the infusion process and the composition of the nutrients.

Common Side Effects: - Phlebitis: inflammation of the vein at the infusion site. - Mild hyperglycaemia: transient elevated blood sugar levels. - Electrolyte imbalance: minor shifts in sodium or potassium levels. - Nausea or vomiting at the infusion site or during the …

Serious or Rare S   t  : -   t  . -  . -  . -  . -  . -  . -  t  . -  . -  . -  . -  . -  t  g . -  . -  . -  . -  . -  t . -  . -  . -   t  g  t. -  t. -  -  t. -  -  -  t -  t -  -  -  -  t - ",

Intro  t   t ewline   

  t ewline